Patents by Inventor Seong-Hyang Sohn

Seong-Hyang Sohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220000943
    Abstract: A pharmaceutical composition or a health functional food composition for preventing or treating Behcet's disease have Tetragenococcus halophilus, a culture thereof or a lysate thereof. In addition, a pharmaceutical composition or a health functional food composition for preventing or treating a herpes simplex virus infection have Tetragenococcus halophilus, a culture thereof or a lysate thereof. The composition may further include a prebiotic compound. The Tetragenococcus halophilus produces lactate, and the lactate can be converted into short-chain fatty acids such as butyrate in the body, can control the expression of activating molecules of dendritic cells, and can effectively prevent or treat Behcet's disease or herpes simplex virus infection.
    Type: Application
    Filed: October 1, 2019
    Publication date: January 6, 2022
    Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventor: Seong Hyang SOHN
  • Publication number: 20150153340
    Abstract: The present invention relates to a composition for the diagnosis of Behcet's disease, comprising an agent for measuring the expression level of macrophage mannose receptor 1 (CD206), a kit for the diagnosis of Behcet's disease, and an information providing method using the same. According to the present invention, it is possible to diagnose the pathogenesis of Behcet's disease without being affected by symptoms of Behcet's disease or prescription drugs and differentially diagnose between active Behcet's disease and inactive Behcet's disease.
    Type: Application
    Filed: June 20, 2014
    Publication date: June 4, 2015
    Inventor: Seong Hyang SOHN
  • Publication number: 20080234218
    Abstract: Disclosed is a double-strand siRNA capable of suppressing interleukin-6 (IL-6) expression, and a pharmaceutical composition containing the same. The siRNA of the present invention and the pharmaceutical composition containing the same may be useful to treat inflammatory diseases, autoimmune diseases, neoplasmic disease and central nervous system diseases, which are all associated with the over-expressed IL-6 level, by lowering an IL-6 level.
    Type: Application
    Filed: May 9, 2006
    Publication date: September 25, 2008
    Inventors: Seong-Hyang Sohn, Hae-Ok Byun, Bun-Soon Choi